Patents Assigned to MBC Pharma, Inc.
  • Patent number: 11324767
    Abstract: Provided herein is a novel method for creating fixed, non-antagonistic molar ratios of drugs in and around the bone environment for desired periods of time. This method enables treating bone and bone-related disease by administering a pharmaceutical composition comprising a bone-targeted therapeutic agent able to release a drug payload from the bone surface, in addition to a second therapeutic agent. Such methods are useful in the treatment of bone and bone-related diseases, such as cancer-induced bone disease, osteomyelitis and bone infection, bone pain and inflammatory bone disease, metabolic disease, as well as others.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: May 10, 2022
    Assignee: MBC PHARMA, INC.
    Inventors: Shawn Zinnen, Alexander Karpeisky
  • Patent number: 11298366
    Abstract: Provided herein are conjugates of nucleoside antimetabolites and their analogs with ibandronate, pharmaceutical compositions including one or more of said conjugates, methods of synthesizing the same as well as methods of treating diseases and or conditions using the same.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: April 12, 2022
    Assignee: MBC Pharma, Inc
    Inventors: Alexander Karpeisky, Shawn Zinnen
  • Publication number: 20190350958
    Abstract: Provided herein is a novel method for creating fixed, non-antagonistic molar ratios of drugs in and around the bone environment for desired periods of time. This method enables treating bone and bone-related disease by administering a pharmaceutical composition comprising a bone-targeted therapeutic agent able to release a drug payload from the bone surface, in addition to a second therapeutic agent. Such methods are useful in the treatment of bone and bone-related diseases, such as cancer-induced bone disease, osteomyelitis and bone infection, bone pain and inflammatory bone disease, metabolic disease, as well as others.
    Type: Application
    Filed: January 5, 2018
    Publication date: November 21, 2019
    Applicant: MBC Pharma, Inc.
    Inventors: Shawn ZINNEN, Alexander KARPEISKY
  • Patent number: 10046055
    Abstract: The present invention provides novel bisphosphonate conjugates, pharmaceutical compositions comprising bisphosphonate conjugates and methods of using such analogs in the treatment of bone cancer, bone-related diseases, bone infection, bone inflammation, and diseases of the soft tissues surrounding bones.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: August 14, 2018
    Assignee: MBC PHARMA, INC.
    Inventors: Alexander Karpeisky, Shawn Patrick Zinnen
  • Patent number: 9334300
    Abstract: Compounds and compositions are provided, as are methods of using them to treat infections, neoplastic disease, including pancreatic cancer, inflammatory disease, and pain. Such compounds are nucleotides, acyclonucleotides, and ANP phosphonates conjugated with forms and/or moieties of Vitamin B6 for delivery past the cell membrane and into the cell.
    Type: Grant
    Filed: August 1, 2012
    Date of Patent: May 10, 2016
    Assignee: MBC PHARMA, INC.
    Inventors: Alexander Karpeisky, Shawn Zinnen, Murali Urlam, Vladimir Y. Vvedensky, Andrei P. Guzaev
  • Patent number: 9216204
    Abstract: The present invention provides novel bisphosphonate conjugates, pharmaceutical compositions comprising bisphosphonate conjugates and methods of using such analogs in the treatment of bone cancer, bone-related diseases, bone infection, bone inflammation, and diseases of the soft tissues surrounding bones.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: December 22, 2015
    Assignee: MBC PHARMA, INC.
    Inventors: Alexander Karpeisky, Shawn Patrick Zinnen
  • Publication number: 20140329768
    Abstract: Provided herein are compounds, compositions, and methods of using them to treat infections, neoplastic disease, inflammatory disease, and pain. Such compounds are nucleotides, acyclonucleotides, and ANP phosphonates conjugated with forms and/or moieties of Vitamin B6 for delivery past the cell membrane and into the cell.
    Type: Application
    Filed: August 1, 2012
    Publication date: November 6, 2014
    Applicant: MBC PHARMA, INC.
    Inventors: Alexander Karpeisky, Shawn Zinnen, Murali Urlam, Vladimir Y. Vvedensky, Andrei P. Guzaev
  • Publication number: 20140051625
    Abstract: The present invention provides novel bisphosphonate conjugates, pharmaceutical compositions comprising bisphosphonate conjugates and methods of using such analogs in the treatment of bone cancer, bone-related diseases, bone infection, bone inflammation, and diseases of the soft tissues surrounding bones.
    Type: Application
    Filed: October 25, 2013
    Publication date: February 20, 2014
    Applicant: MBC Pharma, Inc.
    Inventors: Alexander Karpeisky, Shawn Patrick Zinnen
  • Patent number: 8586781
    Abstract: The present invention provides novel bisphosphonate conjugates, pharmaceutical compositions comprising bisphosphonate conjugates and methods of using such analogs in the treatment of bone cancer, bone-related diseases, bone infection, bone inflammation, and diseases of the soft tissues surrounding bones.
    Type: Grant
    Filed: March 30, 2009
    Date of Patent: November 19, 2013
    Assignee: MBC Pharma, Inc.
    Inventors: Alexander Karpeisky, Shawn Patrick Zinnen
  • Patent number: 7598246
    Abstract: The present invention provides novel bisphosphonate conjugates, pharmaceutical compositions comprising bisphosphonate conjugates and methods of using such analogs in the treatment of bone cancer, bone-related diseases and diseases of the soft tissues surrounding bones.
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: October 6, 2009
    Assignee: MBC Pharma, Inc.
    Inventors: H.B.F. Dixon, Marat Karpeisky, Alexander Karpeisky, legal representative, Nelly Padioukova, Sergey Mikhailov, Grigorii Tzeitline
  • Publication number: 20090227544
    Abstract: The present invention provides novel bisphosphonate conjugates, pharmaceutical compositions comprising bisphosphonate conjugates and methods of using such analogs in the treatment of bone cancer, bone-related diseases, bone infection, bone inflammation, and diseases of the soft tissues surrounding bones.
    Type: Application
    Filed: March 30, 2009
    Publication date: September 10, 2009
    Applicant: MBC PHARMA, INC.
    Inventors: Alexander Karpeisky, Shawn Zinnen